{
  "ptid_time": "041_S_5078_2014-02-28",
  "img_path": "/data/qiuhui/data/adni/images/041_S_5078/2014-02-28/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 43,606 mm³, 95.2% above the reference mean. With a Z-score of 2.38 (99.1th percentile), this represents significant enlargement; hippocampal volume measures 6,687 mm³, 13.0% below the reference mean. With a Z-score of -1.46 (7.3th percentile), this represents mild atrophy; whole brain volume measures 1,015,260 mm³, 1.4% below the reference mean. With a Z-score of -0.17 (43.3th percentile), this represents normal volume ; entorhinal cortex volume measures 3,361 mm³, 13.7% below the reference mean. With a Z-score of -1.06 (14.5th percentile), this represents mild atrophy; fusiform gyrus volume measures 18,510 mm³, 1.6% above the reference mean. With a Z-score of 0.19 (57.4th percentile), this represents normal volume ; middle temporal gyrus volume measures 20,431 mm³, 0.4% below the reference mean. With a Z-score of -0.04 (48.5th percentile), this represents normal volume . ",
  "text_data": "Age is 68.4 years. Gender is Female. Education: 16 years. MMSE: 27.0. MoCA: 22.0. Logical Memory: 16.0. APOEε4 alleles: 0.0. ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant ventricular enlargement (consistent with atrophy) and mild hippocampal and entorhinal cortex atrophy, which are key biomarkers for Alzheimer's disease. The MMSE is normal (27/30), but the MoCA (22/30) suggests mild cognitive impairment, particularly in executive function or visuospatial abilities. The absence of APOE4 reduces genetic risk but does not rule out AD.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amnestic subtype given hippocampal/entorhinal atrophy).  \n\n**Confidence:** **Medium** (imaging supports neurodegeneration, but cognitive scores are borderline, and clinical correlation is needed to exclude other causes).",
  "timestamp": "2025-07-26T07:24:01.038840"
}